Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases

Background & Aims. Flow cytometry is successfully used for diagnosis of malignant lymphoproliferative disorders. However, there are atypical cases that are difficult to interpret; thus, new markers relevant for the differential diagnosis are to be searched for. The aim is to analyze CD200 expres...

Full description

Saved in:
Bibliographic Details
Main Authors: YuV Mirolyubova, EA Stadnik, TS Nikulina, VV Strugov, TO Andreeva, YuV Virts, RV Grozov, AYu Zaritskey
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-04-01
Series:Клиническая онкогематология
Subjects:
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/03/5.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152501014167552
author YuV Mirolyubova
EA Stadnik
TS Nikulina
VV Strugov
TO Andreeva
YuV Virts
RV Grozov
AYu Zaritskey
author_facet YuV Mirolyubova
EA Stadnik
TS Nikulina
VV Strugov
TO Andreeva
YuV Virts
RV Grozov
AYu Zaritskey
author_sort YuV Mirolyubova
collection DOAJ
description Background & Aims. Flow cytometry is successfully used for diagnosis of malignant lymphoproliferative disorders. However, there are atypical cases that are difficult to interpret; thus, new markers relevant for the differential diagnosis are to be searched for. The aim is to analyze CD200 expression in patients with B-cell lymphoproliferative disorders. Materials & Methods. 187 patients with chronic lymphocytic leukemia (CLL), 14 patients with mantle cell lymphoma (MCL), 9 patients with marginal zone lymphoma (MZL), and 5 patients with hairy cell leukemia (HCL) were enrolled in the study. Neoplasm was not confirmed in 12 subjects. The patients underwent the following tests: CBC, immunophenotyping of peripheral blood or bone marrow lymphocytes, and a cytogenetic test. In some cases, an additional immunohistochemical test of bone marrow trepanobiopsy or lymph node biopsy samples was required. Results. In all cases of CLL and HCL, the CD200 expression was positive; mean fluorescence intensity was higher in these cases as compared to other groups. Negative expression of CD200 prevailed in MCL patients; however, at the same time 2 cases of intermediate and positive expression were reported, both showing moderate fluorescence intensity values. CD200 expression was heterogeneous in MZL patients. Conclusion. The CD200 negative expression excludes typical HCL and CLL. Additional cytogenetic and immunnohistoсhemical tests should be performed in such cases to verify the diagnosis, first of all, MCL or MZL.
format Article
id doaj-art-e1d87579db1b4e2ab29a45852a12fd40
institution OA Journals
issn 1997-6933
2500-2139
language Russian
publishDate 2017-04-01
publisher Practical Medicine Publishing House
record_format Article
series Клиническая онкогематология
spelling doaj-art-e1d87579db1b4e2ab29a45852a12fd402025-08-20T02:25:58ZrusPractical Medicine Publishing HouseКлиническая онкогематология1997-69332500-21392017-04-0110216917510.21320/2500-2139-2017-10-2-169-175Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative DiseasesYuV Mirolyubova0EA Stadnik1TS Nikulina2VV Strugov3TO Andreeva4YuV Virts5RV Grozov6AYu Zaritskey7Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Federal Almazov North-West Medical Research Centre, 2 Akkuratova str., Saint Petersburg, Russian Federation, 197341Background & Aims. Flow cytometry is successfully used for diagnosis of malignant lymphoproliferative disorders. However, there are atypical cases that are difficult to interpret; thus, new markers relevant for the differential diagnosis are to be searched for. The aim is to analyze CD200 expression in patients with B-cell lymphoproliferative disorders. Materials & Methods. 187 patients with chronic lymphocytic leukemia (CLL), 14 patients with mantle cell lymphoma (MCL), 9 patients with marginal zone lymphoma (MZL), and 5 patients with hairy cell leukemia (HCL) were enrolled in the study. Neoplasm was not confirmed in 12 subjects. The patients underwent the following tests: CBC, immunophenotyping of peripheral blood or bone marrow lymphocytes, and a cytogenetic test. In some cases, an additional immunohistochemical test of bone marrow trepanobiopsy or lymph node biopsy samples was required. Results. In all cases of CLL and HCL, the CD200 expression was positive; mean fluorescence intensity was higher in these cases as compared to other groups. Negative expression of CD200 prevailed in MCL patients; however, at the same time 2 cases of intermediate and positive expression were reported, both showing moderate fluorescence intensity values. CD200 expression was heterogeneous in MZL patients. Conclusion. The CD200 negative expression excludes typical HCL and CLL. Additional cytogenetic and immunnohistoсhemical tests should be performed in such cases to verify the diagnosis, first of all, MCL or MZL.http://bloodjournal.ru/wp-content/uploads/2017/03/5.pdfCD200flow cytometrydiagnosischronic lymphocytic leukemiamantle cell lymphomamarginal zone lymphomahairy cell leukemia
spellingShingle YuV Mirolyubova
EA Stadnik
TS Nikulina
VV Strugov
TO Andreeva
YuV Virts
RV Grozov
AYu Zaritskey
Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
Клиническая онкогематология
CD200
flow cytometry
diagnosis
chronic lymphocytic leukemia
mantle cell lymphoma
marginal zone lymphoma
hairy cell leukemia
title Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
title_full Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
title_fullStr Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
title_full_unstemmed Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
title_short Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
title_sort role of superficial cd200 marker in differential diagnosis of malignant b cell lymphoproliferative diseases
topic CD200
flow cytometry
diagnosis
chronic lymphocytic leukemia
mantle cell lymphoma
marginal zone lymphoma
hairy cell leukemia
url http://bloodjournal.ru/wp-content/uploads/2017/03/5.pdf
work_keys_str_mv AT yuvmirolyubova roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT eastadnik roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT tsnikulina roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT vvstrugov roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT toandreeva roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT yuvvirts roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT rvgrozov roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases
AT ayuzaritskey roleofsuperficialcd200markerindifferentialdiagnosisofmalignantbcelllymphoproliferativediseases